Drug Shortage Report for BIVALIRUDIN INJECTION

Last updated on 2025-04-24 History
Report ID 253968
Drug Identification Number 02505517
Brand name BIVALIRUDIN INJECTION
Common or Proper name Bivalirudin Injectable 250mg/50mL 10vials
Company Name AVIR PHARMA INC.
Market Status MARKETED
Active Ingredient(s) BIVALIRUDIN
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 10
ATC code B01AE
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2025-04-02
Actual start date
Estimated end date 2025-04-18
Actual end date 2025-04-23
Shortage status Resolved
Updated date 2025-04-24
Company comments We still have inventory, but only shortdated inventory
Health Canada comments
Tier 3 Status No
Contact Address 660 BOULEVARD INDUSTRIEL
BLAINVILLE, QUEBEC
CANADA J7C 3V4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2025-04-24 English Compare
v5 2025-04-23 French Compare
v4 2025-04-23 English Compare
v3 2025-04-03 English Compare
v2 2025-04-02 French Compare
v1 2025-04-02 English Compare

Showing 1 to 6 of 6